Published: 2017-06-15 03:12:00
SUMMARY
Named
2016 Arizona Bioscience Leader of the Year, Mara Aspinall is a biotech industry
executive and healthcare pioneer. Aspinall is President and CEO of
HealthCatalysts, a firm dedicated to the growth of new healthcare
companies. Aspinall is also Executive
Chairman of GenePeeks, a computational genomics company creating a paradigm
shift in genetic testing and personalized medicine. GenePeeks’ proprietary technology can
identify the risk of passing on monogenic disease to progeny pre-conception
through data mining the maternal and paternal genomes. Aspinall is the former President and CEO of
Ventana Medical Systems division of Roche, worldwide leader in development and commercialization
of tissue-based cancer diagnostics. Mara previously spent 12 years as President
of Genzyme Genetics and Genzyme Pharmaceuticals. Genzyme Genetics, set the
standard for quality in the diagnostics industry leading the market in prenatal
and cancer testing. The business was sold to LabCorp for $1 billion. Aspinall
is a member of the Board of Directors of Safeguard Scientifics (NYSE:SFE),
Abcam plc (AIM:ABC), Blue Cross Blue Shield Arizona, Castle Biosciences and
SenesTech.
